NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/21/2024
Back to search
Official data from USPTO
GENESIS VECTOR MANUFACTURING SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GENESIS VECTOR MANUFACTURING SOLUTIONS
ST13
US500000097705178Class
40, 42
Filing
97705178
Registration
7393135
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
05/21/2024
Trademark type
Word
Nice classes
40, 42
Filing date
12/06/2022
Registration date
05/21/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/21/2024
Last transaction
05/21/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/22/2024
First use in commerce
01/22/2024
Drawing code
4
Owner type
16
Owner location
KING OF PRUSSIA, PA, US
Examiner
RUMMERY, MARY M
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CENTER FOR BREAKTHROUGH MEDICINES HOLDINGS, LLC
Representatives
Joshua M. Gerben, Esq. GERBEN PERROTT, PLLC
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Manufacturing services for others in the fields of gene therapymodified gene therapycell therapytissue engineering and biopharmaceuticalsplasmid DNA production; manufacturing services for others in the fields of mammalian cell banksplasmidsadenovirusadeno-associated virus (AAV)bacteriophagelentivirusretroviruses and other viruses found in humans and animals; manufacturing process consulting
Class 42
Research and development services in the fields of gene therapymodified gene therapycell therapytissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapymodified gene therapycell therapytissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapymodified gene therapycell therapytissue engineering and biopharmaceuticals; scientific research and technical research servicesproduction of cell lines for others using lentivirus technology; scientific research and technical research services relating to producingassaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producingassayingpurifying adenovirusadeno-associated virus (AAV)bacteriophagelentivirusretroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for otherscGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management servicesquality evaluation and analysisquality assurancequality controlin the fields of gene therapymodified gene therapycell therapytissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research; research and development in the field of gene therapy accelerationvector genome copy titersdroplet digital polymerase chain reaction (PCR) and digital polymerase chain reaction (PCR)mass spectrometrycapsid characterizationbioassaysplasmid DNAanalytics testing in the field of genes and gene therapy
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/21/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/18/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/17/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/29/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/29/2024
IUAF
USE AMENDMENT FILED
02/06/2024
EISU
TEAS STATEMENT OF USE RECEIVED
02/06/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/26/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/31/2023
PUBO
PUBLISHED FOR OPPOSITION
10/31/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/11/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/20/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/20/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/20/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/18/2023
GNRT
NON-FINAL ACTION E-MAILED
09/18/2023
CNRT
NON-FINAL ACTION WRITTEN
09/18/2023
DOCK
ASSIGNED TO EXAMINER
09/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/09/2022
NWAP
NEW APPLICATION ENTERED
12/09/2022
Continuous trademark protection
Get notified about every new filing that threatens GENESIS VECTOR MANUFACTURING SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.